OMNIPAQUE 240
GE HEALTHCARE CANADA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of OMNIPAQUE 240 in Canada?
A shortage of OMNIPAQUE 240 518MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 8, 2026), but it has not started yet.
When will OMNIPAQUE 240 be available again?
The manufacturer's estimated resolution date is October 29, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
OMNIPAQUE 180 LIQ SAR 388MG/ML
SANOFI CANADA, INC.
OMNIPAQUE 350
GE HEALTHCARE CANADA INC
OMNIPAQUE 300
GE HEALTHCARE CANADA INC
OMNIPAQUE 240 LIQ IV SAR 518MG/ML
SANOFI CANADA, INC.
OMNIPAQUE 300 LIQ IV SAR 647MG/ML
SANOFI CANADA, INC.
OMNIPAQUE 350 LIQ IV 755MG/ML
SANOFI CANADA, INC.
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-10-29
~31 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02172739
Strength
518MG
Dosage Form
SOLUTION
Route
RECTAL ORAL INTRA-ARTICULAR INTRAVASCULAR SUBARACHNOIDAL
Active Ingredient
IOHEXOL
Tier
Unrated
Last Updated
2026-09-08
Reason for Shortage
Other (Please describe in comments)
Past Reports for This Drug
OMNIPAQUE 240 has 6 shortage/discontinuation reports on file — this is one of them.
Other (Please describe in comments)
Other (Please describe in comments)
Business reasons
Shortage of an inactive ingredient or component.
Other (Please describe in comments)
Other Products from GE HEALTHCARE CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.